SARS-CoV-2 Vaccine Response in Patients With Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis

• Lauren Floyd,
• Mohamed E. Elsayed,
• Tobias Seibt,
• Anke von Bergwelt-Baildon,
• Philip Seo,
• Brendan Antiochos,
• Sam Kant,
• Adam Morris,
• Ajay Dhaygude,
• Ulf Schönermarck,
• Duvuru Geetha

Affiliations

Lauren Floyd

Department of Nephrology, Royal Preston Hospital, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK

Mohamed E. Elsayed

Department of Nephrology, Royal Preston Hospital, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK

Tobias Seibt

Nephrology Division, Department of Medicine IV, University Hospital, LMU Munich, Munich, Germany

Anke von Bergwelt-Baildon

Nephrology Division, Department of Medicine IV, University Hospital, LMU Munich, Munich, Germany

Philip Seo

Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, USA

Brendan Antiochos

Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, USA

Sam Kant

Division of nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, USA

Adam Morris

Department of Nephrology, Royal Preston Hospital, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK

Ajay Dhaygude

Department of Nephrology, Royal Preston Hospital, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK

Ulf Schönermarck

Nephrology Division, Department of Medicine IV, University Hospital, LMU Munich, Munich, Germany

Duvuru Geetha

Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, USA; Division of nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, USA; Correspondence: Duvuru Geetha, Department of Medicine, Johns Hopkins University School of Medicine, 301 Mason Lord Drive, Baltimore, Maryland 21224, USA.